MedTrace Logo

Laser Prostatectomy Database and Registry

NCT00159406 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2025-01-23

No results posted yet for this study

Summary

STATEMENT OF PURPOSE:

Transurethral resection of the prostate (TURP) is the standard surgical intervention for obstructive benign prostatic hyperplasia (BPH) in all but the largest of glands, which are typically treated with open simple prostatectomy. Recently, new generation lasers (holmium and potassium titanyl phosphate \[KTP\]) have been utilized for BPH treatment. Long-term follow-up of laser prostatectomy outcomes must be documented to fully characterize the degree of voiding improvement achievable by these new techniques, the durability of these outcomes, and the safety profiles of these procedures.

Conditions

  • Benign Prostatic Hyperplasia
  • Enlarged Prostate

Interventions

OTHER

Registry and Database

Data Collection

Sponsors & Collaborators

  • Indiana Kidney Stone Institute

    lead OTHER

Principal Investigators

  • James E Lingeman, MD · IU Health Physicians Urology

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-10-31
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00159406 on ClinicalTrials.gov